Raphael Mechoulam

This inventor holds 44 USPTO granted patents and 16 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Cannabinoid Therapeutics. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Federal University of Rio Grande Do Sul, Ramot University Authority for Applied Research and Industrial Development Limited. Active years: 1979-2025.

USPTO Granted Patents = 44 (Patent Applications = 16)

% Patents Active = 70.5

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 10 (Patent Applications = 17)

Average Co-Inventor Count = 3.9

ph-index = 16

Forward Citations = 732(Granted Patents)

Company Filing History:

38 out of 910

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

patents

3 out of 26

Federal University of Rio Grande Do Sul

patents

3 out of 165

Ramot University Authority for Applied Research and Industrial Development Limited

patents

4. 3 out of 31

University of São Paulo

patents

5. 2 out of 180

Hadasit Medical Research Services and Development Ltd.

Aristotle University of Thessaloniki

National Institute of Health and Medical Research

12. 7 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1979-2025

Loading Chart...

Areas of Expertise:

Cannabinoid Acid Esters

Fatty Acid Amides

Pain Treatment

Anti-Inflammatory Agents

Addiction Disorders

Cannabidiol Derivatives

Neuroprotective Pharmaceuticals

Osteoporosis Treatment

Pharmaceutical Compositions

Therapeutic Uses

CB Receptor Agonists

Synthetic Endogenous Cannabinoids

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12403114 - Cannabinoid acid ester compositions and uses thereof (2025-09-02),

2. 11440870 - Cannabidiolic acid esters compositions and uses thereof (2022-09-13),

3. 11324709 - Fatty acid amides and uses thereof in the treatment of addiction disorder and addiction related conditions (2022-05-10),

4. 11149014 - Method for treating pain or associated condition or symptom (2021-10-19),

5. 11058652 - Methods for treatment of Prader-Willi syndrome (2021-07-13),

6. 10441553 - Fluorinated CBD compounds, compositions and uses thereof (2019-10-15),

7. 10239848 - Cyclohexenyl compounds, compositions comprising them and uses thereof (2019-03-26),

8. 10166202 - Treatment of hepatic encephalopathy and liver cirrhosis (2019-01-01),

9. 9782360 - Fluorinated CBD compounds, compositions and uses thereof (2017-10-10),

10. 9447019 - Fluorinated CBD compounds, compositions and uses thereof (2016-09-20),

11. 9428431 - Compositions comprising CB receptor agonists, uses thereof and methods for their preparation (2016-08-30),

12. 9365534 - Arylated camphenes, processes for their preparation and uses thereof (2016-06-14),

13. 8722938 - Arylated camphenes, processes for their preparation and uses thereof (2014-05-13),

14. 8497299 - Compositions including quinonoid derivatives of cannabinoids for therapeutic use (2013-07-30),

15. 8198327 - Fatty acid amides and uses thereof (2012-06-12),

Title: The Pioneer of Cannabis Research - Raphael Mechoulam

Introduction: Raphael Mechoulam, a distinguished inventor hailing from Jerusalem, Israel, is renowned for his groundbreaking contributions to the field of cannabis research. His innovative work has significantly advanced our understanding of the medicinal properties of cannabis.

Latest Patents: As a prominent figure in the field of cannabis research, Mechoulam has been involved in numerous patents related to the extraction, synthesis, and potential medical applications of cannabinoids. His patents have paved the way for further developments in the use of cannabis-based treatments.

Career Highlights: Mechoulam's illustrious career spans several decades, during which he has conducted extensive research on the chemistry and pharmacology of cannabinoids. He is credited with the isolation and elucidation of the structure of THC, the primary psychoactive component of cannabis, a discovery that revolutionized the field.

Collaborations: Throughout his career, Mechoulam has collaborated with leading scientists, researchers, and medical professionals from around the world to further explore the potential therapeutic benefits of cannabinoids. His collaborative efforts have led to significant advancements in the field of cannabis research.

Conclusion: Raphael Mechoulam's pioneering work in cannabis research has had a profound impact on the scientific community and the medical field. His dedication to unraveling the mysteries of cannabinoids has laid the foundation for the development of innovative treatments and therapies. Mechoulam's contributions continue to inspire further research and exploration in the field of cannabis science.